Evidence map›Paper›PMID 33737524›Full record

ArticleScientific reports2021

Diverse metabolic response of cancer cells treated with a

Benedikt Feuerecker, Philipp Biechl, Christof Seidl, Frank Bruchertseifer, Alfred Morgenstern, Markus Schwaiger, Wolfgang Eisenreich

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Nanoscale Radiotheranostics for Cancer Treatment: From Bench to Bedside.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Benedikt FeuereckerDepartment of Nuclear Medicine, School of Medicine, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany. benedikt.feuerecker@tum.de.
Philipp BiechlDepartment of Chemistry, Bavarian NMR Center-Structural Membrane Biochemistry, Technische Universität München, Garching, Germany.
Christof SeidlDepartment of Nuclear Medicine, School of Medicine, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.
Frank BruchertseiferEuropean Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
Alfred MorgensternEuropean Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
Markus SchwaigerDepartment of Nuclear Medicine, School of Medicine, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.
Wolfgang EisenreichDepartment of Chemistry, Bavarian NMR Center-Structural Membrane Biochemistry, Technische Universität München, Garching, Germany.
Technical University of Munich · DEJoint Research Centre · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evaluation of treatment response is among the major challenges in modern oncology. We herein used a monoclonal antibody targeting the EGF receptor (EGFR) labelled with the alpha emitter

Indexed as

Amino AcidsAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBiological TransportBismuthCarbon IsotopesCell Line, TumorDose-Response Relationship, DrugEpithelial CellsErbB ReceptorsGas Chromatography-Mass SpectrometryGlucoseHumansImmunoconjugatesNeurogliaRadioisotopesAmino AcidsAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBismuthCarbon IsotopesEGFR protein, humanErbB ReceptorsGlucoseImmunoconjugatesmatuzumabRadioisotopes

Identifiers

PMID33737524
PMCPMC7973706
OpenAlexW3136840874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.